Are FUT2 rs602662 GG and CUBN rs1801222 GG linked to lower vitamin B12 status?

Genetic variations in the FUT2 and CUBN genes play critical, distinct roles in regulating systemic vitamin B12 status by altering mucosal biology and active absorption pathways in the gut.

Mechanistic pathways of mucosal and receptor transport

• FUT2-mediated mucosal changes: The FUT2 rs602662 GG genotype represents active secretor status. It encodes functional alpha(1,2)-fucosyltransferase, which synthesizes H-type mucosal glycans. These glycans alter the gut microbiota composition (affecting bacterial B12 competition), decrease gastric intrinsic factor (GIF) secretion, and increase the hepatic clearance rate of haptocorrin by altering its glycosylation pattern.
• CUBN-mediated receptor endocytosis: The CUBN rs1801222 variant (p.Ser253Phe) alters the functional efficiency of the cubilin receptor on ileal enterocytes. This receptor, complexed with amnionless, mediates clathrin-dependent endocytosis of the intrinsic factor-vitamin B12 (IF-B12) complex, directly regulating ileal absorption capacity.

Clinical and pharmacological interactions

• Systemic B12 impact: Genome-wide association studies link both genetic loci to circulating B12 concentrations. While the FUT2 GG genotype is a robust predictor of lower serum B12 levels, the impact of CUBN rs1801222 is highly context-dependent.
• Exacerbating factors: Although the CUBN G allele is often the higher-functioning reference, specific cohorts (such as a Canadian study) have linked it to elevated deficiency risk. Furthermore, environmental stressors like chronic metformin therapy pharmacologically impair cubilin-mediated endocytosis, worsening B12 malabsorption across genotypes.

Bottom line

• The FUT2 rs602662 GG and CUBN rs1801222 variants significantly modulate systemic vitamin B12 status through complementary pathways: FUT2 influences mucosal glycan-driven clearance and gastric secretion, while CUBN alters ileal receptor-mediated absorption, with risks further compounded by clinical stressors like metformin therapy.